| Lisa K Snyder, MD | |
|
3500 Fetchet Ave, Andrews Air Force Base, MD 20762-5157 | |
| (301) 836-8553 | |
| Not Available |
| Full Name | Lisa K Snyder |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 3500 Fetchet Ave, Andrews Air Force Base, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023040946 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 0101054651 (Virginia) | Primary |
| Entity Name | Geisinger Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366493868 PECOS PAC ID: 5395657001 Enrollment ID: O20040130000518 |
News Archive
A team of researchers from the National University of Singapore has uncovered the mystery behind the potent parasite-killing effect of artemisinin, a drug that is considered to be the last line of defence against malaria. Given the emergence of artemisinin resistance, these findings could potentially lead to the design of new treatments against drug-resistant parasites.
Takeda Pharmaceutical Company Limited announced today that it has voluntarily decided to end the development program for orteronel (TAK-700) for prostate cancer. The decision follows the results of two Phase 3 clinical trials in metastatic, castration resistant prostate cancer (mCRPC).
The owners of AvaCare Medical, an online medical supply store, have announced their recent acquisition of Medical Scrubs Collection, an online supplier for medical scrubs.
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, today announced that the Company has closed its previously announced securities offering, raising over $9.3 million in gross proceeds. Apricus Bio intends to use the proceeds from this offering for product and technology development and general corporate purposes. Dawson James Securities acted as the exclusive placement agent for the offering.
The W. M. Keck Foundation has awarded $250,000 to the University of Utah to establish a new undergraduate minor in dark sky studies, the first of its kind in the United States.
› Verified 9 days ago
| Entity Name | Emergency Care Services Of Pennsylvania Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114955010 PECOS PAC ID: 1759301799 Enrollment ID: O20051206000046 |
News Archive
A team of researchers from the National University of Singapore has uncovered the mystery behind the potent parasite-killing effect of artemisinin, a drug that is considered to be the last line of defence against malaria. Given the emergence of artemisinin resistance, these findings could potentially lead to the design of new treatments against drug-resistant parasites.
Takeda Pharmaceutical Company Limited announced today that it has voluntarily decided to end the development program for orteronel (TAK-700) for prostate cancer. The decision follows the results of two Phase 3 clinical trials in metastatic, castration resistant prostate cancer (mCRPC).
The owners of AvaCare Medical, an online medical supply store, have announced their recent acquisition of Medical Scrubs Collection, an online supplier for medical scrubs.
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, today announced that the Company has closed its previously announced securities offering, raising over $9.3 million in gross proceeds. Apricus Bio intends to use the proceeds from this offering for product and technology development and general corporate purposes. Dawson James Securities acted as the exclusive placement agent for the offering.
The W. M. Keck Foundation has awarded $250,000 to the University of Utah to establish a new undergraduate minor in dark sky studies, the first of its kind in the United States.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lisa K Snyder, MD 5948 Wescott Hills Way, Alexandria, VA 22315-4742 Ph: (757) 613-4202 | Lisa K Snyder, MD 3500 Fetchet Ave, Andrews Air Force Base, MD 20762-5157 Ph: (301) 836-8553 |
News Archive
A team of researchers from the National University of Singapore has uncovered the mystery behind the potent parasite-killing effect of artemisinin, a drug that is considered to be the last line of defence against malaria. Given the emergence of artemisinin resistance, these findings could potentially lead to the design of new treatments against drug-resistant parasites.
Takeda Pharmaceutical Company Limited announced today that it has voluntarily decided to end the development program for orteronel (TAK-700) for prostate cancer. The decision follows the results of two Phase 3 clinical trials in metastatic, castration resistant prostate cancer (mCRPC).
The owners of AvaCare Medical, an online medical supply store, have announced their recent acquisition of Medical Scrubs Collection, an online supplier for medical scrubs.
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, today announced that the Company has closed its previously announced securities offering, raising over $9.3 million in gross proceeds. Apricus Bio intends to use the proceeds from this offering for product and technology development and general corporate purposes. Dawson James Securities acted as the exclusive placement agent for the offering.
The W. M. Keck Foundation has awarded $250,000 to the University of Utah to establish a new undergraduate minor in dark sky studies, the first of its kind in the United States.
› Verified 9 days ago